Private Equity Hub -- CerviLenz Inc., a Cleveland-based maker of disposable devices used to predict the risk of preterm birth in pregnant women, has raised $4 million in first-round funding. Arboretum Ventures led the round, and was joined by Chrysalis Ventures.
